Hovione will invest €2m ($3m) in a new R&D unit in Lisbon. The facility, which will be the base for the company's drug R&D efforts, will focus on the design, development and characterisation of nano- and micro-particles for novel delivery applications.
Outsourcing Pharma
Sunday 24 May 2009
Hovione invests in R&D unit
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment